MUCOSTAR SCIR FL 200ML 50MG/ML

MUCOSTAR 50 MG/ML

active ingredients

50 mg/ml syrup 100 ml syrup contain: Active ingredient: carbocysteine 5 g Excipients: sucrose, p-hydroxybenzoate methyl, p-hydroxybenzoate propile For the full list of excipients, see paragraph 6.1.

Excellent

Saccarosio, glycerine, p-hydroxybenzoate methyl, p-hydroxybenzoate propile, aroma (a soda aroma of champagne), purified water q.b. 100 ml, hydroxide sodium q.b. at pH 6 approximately.

Therapeutic indications

Mucolitic and fluidifying in the acute and chronic affections of the respiratory system.

Contraindications

Hypersensitivity to the active ingredient or any of the excipients. Gastroduodenal ulcers. Pregnancy and nursing. The drug is contraindicated in children under 2 years of age.

Population

Second prescription. Keeping in mind the average body weights at various ages, the following posological scheme may be suggested: - adults and children over 13-15 years: three tablespoons per day; - children from 2 to 5 (5-20 kg): 1/2 - 2 tablespoons of coffee per day from 5 to 10 years (20-30 Kg): 2 - 3 teaspoons of coffee per day from 10 to 12 years (30-40 Kg): 3 - 4 teaspoons of coffee per day The syrup should be administered away from meals, in two-three administrations at regular intervals of time.

Conservation

Store at room temperature.

Warnings

Mucolitics may induce bronchial obstruction in children under two years of age. In fact the drainage capacity of the bronchial mucus is limited in this age range, due to the physiological characteristics of the respiratory tract. They must not be used in children under two years (see 4.3). The medicinal product contains: p-hydroxybenzoate methyl, p-hydroxybenzoate propile that can cause allergic reactions (also delayed). The medicine contains: sucrose, patients suffering from rare hereditary problems of fructose intolerance, glucose-galactose mal absorption, or from insufficiency of isomaltase sucrasis, should not take this medicine.

Interactions

There are no known interactions and incompatibility with other drugs.

Effects

They can occur: the appearance of dizziness and digestive phenomena (gastralgies, nausea, diarrhea). In this case it is necessary to reduce posology or stop therapy. In addition, allergic rashes and anaphylactic reactions, fixed erythema may occur. In such cases stop treatment and consult your doctor to establish suitable therapy. It has been reported bronchial obstruction, with unknown frequency.

Overdosing

Symptoms due to overdose include: headaches, nausea, diarrhea, gastralgia. In this case it is useful to cause vomiting or to practice gastric lavender.

Although the active ingredient is neither teratogenic nor mutagenic and has not shown any adverse effects on the reproductive function in the animal, data on its use in human pregnancy are not available. Therefore the use of the medicinal product is contraindicated in pregnancy. Since there is no data on the passage of carboxysteine in breast milk, the use of the medicinal product is contraindicated during breastfeeding.

Source: Farmadati